Naltrexone Treatment Centers in Utah

Yes. Providers in Utah must document a current OUD diagnosis to prescribe naltrexone as part of medication-assisted treatment. The intake assessment typically takes 60–90 minutes and includes a physical exam, drug screen, and psychiatric history — results are used to confirm eligibility.

Cash-pay monthly cost for Sublocade in Utah typically runs $1,400–$1,900 per injection, plus administration fees. Manufacturer savings programs, 340B pricing at FQHCs, and State Opioid Response grants can significantly reduce this out-of-pocket cost.

Yes — Utah Medicaid can pay retroactively for up to 3 months of prior treatment in most cases, provided you were eligible during that period. Save all receipts and itemized statements from naltrexone providers and submit them to the Medicaid enrollment caseworker.

Yes. Utah commercial plans cover Sublocade under the medical benefit (administered in clinic) with prior authorization documenting adherence to sublingual buprenorphine. The naltrexone provider’s office handles the PA paperwork.

Clinics maintain a confidential medical record covering diagnosis, treatment plan, drug screens, counseling notes, and dose history. Records are protected by 42 CFR Part 2 — stricter than HIPAA — and cannot be released without your written consent or a specific court order.

Common reasons include lifestyle stabilization (patient and clinician agree to taper), cost barriers, side effects, travel or employment disruption, and desire to try naltrexone after tapering. Many patients resume treatment later — clinics welcome return visits without judgment.

Yes. Transferring to a different Utah provider is routine; the new clinic will request records with your consent and continue your current dose. There is no penalty for switching providers — clinical compatibility matters.

Sometimes. Comfort medications for withdrawal (clonidine, ondansetron, loperamide) may be prescribed alongside naltrexone at your first visit. Utah clinicians will also address any mental-health medications, pain control, or chronic-disease meds that need coordination.

Buprenorphine and methadone do not test positive on standard 5-panel drug tests — specialty panels are needed. Naltrexone and its metabolites are not screened on standard panels. Share an MAT provider letter with any employer or court drug-testing program to avoid confusion.

Yes. Utah Medicaid covers MAT during pregnancy and for 12 months postpartum in Utah, with priority access and typically no cost-sharing. Pregnancy Medicaid applications are fast-tracked in most Utah counties — ask at intake.

No — counselors with master’s-level licensure (LCSW, LPC, LMFT) provide therapy but do not prescribe medication. A nurse practitioner, physician assistant, or physician on the Utah MAT team handles the prescription. Counselor and prescriber collaborate on your care plan.

No. Legally prescribed methadone, buprenorphine, or naltrexone does not violate employment drug-testing policies when documented by your MAT clinician. Notify the Medical Review Officer (MRO) of your prescription — do not test positive without MRO notification.